Acumen Pharmaceuticals
Acumen Pharmaceuticals

Ritedose Revolutionizes Drug Manufacturing with Innovation!
**Excerpt:** 🌍 Ritedose is revolutionizing sterile drug manufacturing with innovative BFS technology, focusing on patient-centric solutions and quality. 🚀✨

Lonza Partners with CMAC for Advanced Drug Manufacturing
🌟 Lonza joins CMAC in Glasgow! This partnership boosts particle technology and enhances drug manufacturing efficiency. 🤝💊 PharmaInnovation ContinuousManufacturing

Uniphar Boosts Global Reach with New Facilities!
Uniphar expands globally! 🌍 New facilities in Raleigh, Lelystad, and Dublin enhance critical therapy delivery. 📦🥶 Growth in key markets!

Samabriva Unveils High-Tech Plant-Based Factory in Belgium!
🌱 Exciting news! Samabriva opens a new biomanufacturing facility in Belgium, focusing on high-value natural molecules for pharmaceuticals. 💰🚀

Ligand Pharma Snaps Up Apeiron Biologics for $100M
📢 Ligand Pharma acquires Apeiron Biologics for $100M, invests $4M in invIOs Holding AG, and offers future event-based considerations. 🏢💰🏥🤝📅

Revolutionary Supor Prime Filters: The Ultimate Solution for High-Concentration Therapies
🔍 Discover Supor Prime Filters: a reliable filtration solution for high-concentration therapies, ensuring safe and effective manufacturing processes. 🌡️💧🔬💪🏥

Lonza Partners with Acumen for Alzheimer’s Breakthrough
📰 Lonza teams up with Acumen to make sabirnetug, a groundbreaking Alzheimer's therapy, at their New Hampshire facility. 👥 🧪 Sabirnetug targets toxic amyloid beta oligomers, offering hope in the fight against Alzheimer's. 💡 ⏩ Exciting collaboration to speed up Alzheimer's treatment development. Lonza Acumen AlzheimersTherapy Sabirnetug






